Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V <sub>1b</sub> receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Guy Griebel, Jacques Simiand, Claudine Serradeil-Le Gal, Jean Wagnon, Marc Pascal et al.

Proceedings of the National Academy of Sciences • 2002

DOI PMC

Fear/Anxiety Defense Test Battery

behavioralrodent (rats and mice)Not specified

Objective: An atypical anxiety model involving traumatic stress exposure to measure fear and defense-related behaviors in response to vasopressin V1b receptor antagonist treatment

Materials & Equipment Checklist

7 items2 from ConductScience

Gather these items before starting the experiment. Check off items as you prepare.

Equipment5

Elevated plus-maze

Not specified • Not specified • Not specified • Not specified

$1,890

Light/dark test apparatus

Not specified • Not specified • Not specified • Not specified

Amazon

Punished drinking apparatus

Not specified • Not specified • Not specified • Not specified

Amazon

Fear/anxiety defense test battery apparatus

Not specified • Not specified • Not specified • Not specified

Amazon

Forced swimming test apparatus

Not specified • Not specified • Not specified • Not specified

View

Materials2

SSR149415

Sanofi-Synthelabo Recherche • Not specified • Not specified • Not specified

Amazon

Diazepam

Not specified • Not specified • Not specified • Not specified

2 items available from ConductScience

Estimated: $1,890.00

Request Quote

As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V <sub>1b</sub> receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Fear/Anxiety Defense Test Battery

Equipment5

Materials2

Protocol Steps

Fear/Anxiety Defense Test Battery Administration

SSR149415 Administration

Behavioral Observation